Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets
- PMID: 12480259
- DOI: 10.1016/s0198-8859(02)00754-1
Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets
Abstract
The induction of antigen-specific tolerance is critical for maintaining immune homeostasis and preventing autoimmunity. Because the central tolerance that eliminates potentially harmful autoreactive T cells is incomplete, peripheral mechanisms for suppressing self-reactive T cells play an important role. Dendritic cells (DCs) are professional antigen-presenting cells, which have an extraordinary capacity to stimulate naïve T cells and initiate primary immune responses. Recent accumulating evidence indicates that several subsets of human DCs also play a critical role in the induction of peripheral tolerance by anergizing effector CD4(+) and CD8(+) T cells or by inducing the differentiation of naïve T cells into T-regulatory cells, which produce interleukin (IL)-10. Human DC subsets with the property of suppressing an antigen-specific T-cell response include plasmacytoid DCs, which are either in an immature state or in a mature state induced by CD40 ligand stimulation, and monocyte-derived DCs, which are either in an immature state or have had their state modulated by treatment with IL-10 or CD8(+)CD28(-) T cells. These "tolerogenic" DCs may be relevant to therapeutic applications for autoimmune and allergic diseases as well as organ transplant rejection.
Similar articles
-
Immature, but not inactive: the tolerogenic function of immature dendritic cells.Immunol Cell Biol. 2002 Oct;80(5):477-83. doi: 10.1046/j.1440-1711.2002.01115.x. Immunol Cell Biol. 2002. PMID: 12225384 Review.
-
Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells.J Immunol. 2010 Feb 15;184(4):1765-75. doi: 10.4049/jimmunol.0902133. Epub 2010 Jan 18. J Immunol. 2010. PMID: 20083662
-
Human plasmacytoid-derived dendritic cells and the induction of T-regulatory cells.Hum Immunol. 2002 Dec;63(12):1149-55. doi: 10.1016/s0198-8859(02)00753-x. Hum Immunol. 2002. PMID: 12480258 Review.
-
Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.Blood. 2006 May 1;107(9):3632-8. doi: 10.1182/blood-2005-11-4497. Epub 2006 Jan 5. Blood. 2006. PMID: 16397128 Free PMC article.
-
Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.Front Immunol. 2018 Mar 19;9:455. doi: 10.3389/fimmu.2018.00455. eCollection 2018. Front Immunol. 2018. PMID: 29616018 Free PMC article. Review.
Cited by
-
Tolerogenic and activatory plasmacytoid dendritic cells in autoimmunity.Front Immunol. 2013 Mar 6;4:59. doi: 10.3389/fimmu.2013.00059. eCollection 2013. Front Immunol. 2013. PMID: 23508732 Free PMC article.
-
The response of human dendritic cells to co-ligation of pattern-recognition receptors.Immunol Res. 2012 Apr;52(1-2):20-33. doi: 10.1007/s12026-012-8279-5. Immunol Res. 2012. PMID: 22392051 Review.
-
Tolerogenic Dendritic Cells and T-Regulatory Cells at the Clinical Trials Crossroad for the Treatment of Autoimmune Disease; Emphasis on Type 1 Diabetes Therapy.Front Immunol. 2019 Feb 6;10:148. doi: 10.3389/fimmu.2019.00148. eCollection 2019. Front Immunol. 2019. PMID: 30787930 Free PMC article. Review.
-
Equine CD4(+) CD25(high) T cells exhibit regulatory activity by close contact and cytokine-dependent mechanisms in vitro.Immunology. 2011 Nov;134(3):292-304. doi: 10.1111/j.1365-2567.2011.03489.x. Immunology. 2011. PMID: 21977999 Free PMC article.
-
Strategies for treating autoimmunity: novel insights from experimental myasthenia gravis.Ann N Y Acad Sci. 2008;1132:276-82. doi: 10.1196/annals.1405.023. Ann N Y Acad Sci. 2008. PMID: 18567878 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials